Stock Updates

Is this Large Market Cap Stock target price reasonable for Teva Pharmaceutical Industries Limited (NYSE:TEVA)?

The company in question is, Teva Pharmaceutical Industries Limited (NYSE:TEVA) currently with a stock price of 41.79 (-2.72% today). The market cap for Teva Pharmaceutical Industries Limited is 43846.07, and is in the sector Healthcare, and Drug Manufacturers – Other industry. The target price for Teva Pharmaceutical Industries Limited is 66.82. Currently Teva Pharmaceutical Industries Limited is trading with a P/E of 27.9, and a forward P/E of 7.1. Average volume for Teva Pharmaceutical Industries Limited is 6268.36 and so far today it is 11282500.

Performance in the last year for Teva Pharmaceutical Industries Limited has been -29.62%. For EPS growth, Teva Pharmaceutical Industries Limited has seen a growth of -48.90%, and is looking to grow in the next year to 13.08%. More long term stats show that EPS growth has been -13.10% over the last five years and could be 4.56% for the next five years. Teva Pharmaceutical Industries Limited has seen sales growth quarter over quarter at 1.40%, with EPS growth quarter over quarter at -67.40%. The 20-day simple moving average is -16.59%, with the 200-day simple moving average coming to -22.12%.

Since the IPO date for Teva Pharmaceutical Industries Limited on the 3/26/1990, Teva Pharmaceutical Industries Limited has seen performance year to date to be -35.11%. With Teva Pharmaceutical Industries Limited trading at 41.79, the dividend yield is 3.25%, and the EPS is 1.5.

So could Teva Pharmaceutical Industries Limited, be undervalued? Well as said before P/E is 27.9. The PEG is 6.11, P/S is 2.24 and the P/B is at 1.27. The P/cash is 6.28, with P/free cash flow at 8.69.

Teva Pharmaceutical Industries Limited ability to deal with debt shows that the current ratio is 1.3, and the quick ratio is 1. This is with long term debt/equity at 0.27, and total debt/equity at 0.36.

In terms of margins, Teva Pharmaceutical Industries Limited has a gross margin of 57.70%, an operating margin of 17.70% and a profit margin of 6.90%.Payout ratio for Teva Pharmaceutical Industries Limited is 67.50%. Return on assets come to 2.50% with return on investment coming to 5.70%.

Insider ownership for Teva Pharmaceutical Industries Limited, is at 2.70% and institutional ownership comes to 59.30%. Outstanding shares are at 1049.2. While shares float is 1014.18. The float short is currently 1.09%, and short ratio is 1.76.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment